SaRS-Cov-2 Antibodies Following Exposure to COVID-19 and/or Vaccination in Nursing Homes
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,293
- 试验地点
- 1
- 主要终点
- Levels of SARS-COV-2 antibodies
研究概览
简要总结
Presence of SaRS-Cov-2 antibodies following exposure to Coronavirus Disease 2019 (COVID-19) and/or vaccination is a major indicator of immunization. Few data exit about serology response in nursing homes (NHs), i.e. in the most vulnerable population for developing severe forms of the disease.
Residents and health professionals in 9 nursing homes (NHs) with SaRS-Cov-2 antibodies detection after exposure (either COVID-19 or vaccine) All biological tests were performed in the frame of the standard care of residents and health professionals and all participants did not express opposition for using anonymously their data for the purpose of this academic analysis. In addition all Directors and Physicians of these NHs accepted to participate in this study
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 20 Years 至 110 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •For Residents:
- •Living in one of the 9 Nursing Homes that participate in this study
- •Having a SARS-COV-2 post vaccination serology.
- •Having no objection for using the results of the serology for the purpose of this analysis
- •For Health Professionals:
- •Working in one of the 9 Nursing Homes that participate in this study,
- •Having a SARS-COV-2 post vaccination serology.
- •Having no objection for using the results of the serology for the purpose of this analysis
排除标准
- 未提供
结局指标
主要结局
Levels of SARS-COV-2 antibodies
时间窗: Through study completion average 6 months Retrospective analysis
Study of the SARS-COV-2 antibodies according to the history of COVID-19 and vaccinal status in Nursing Home residents and in health professionals
次要结局
未报告次要终点
研究者
Pr Athanase BENETOS
Athanase Benetos, Clinical Professor, Head of the Dpt of Geriatrics
Central Hospital, Nancy, France